Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$258.66M
Total Bought
$53.58M
Total Sold
$9.74M
Net Transaction
+$43.84M
Filing Period:
Securities
SharesValue ($K)
Q3 2025
Q4 2025
Change
Q3 2025
Q4 2025
Weight (%)
Change
EVOMMUNE INC01,926,943+1,926,943032,98912.75%+32,989
VAXCYTE INC(PCVX)1,372,4251,372,425049,43563,32424.48%+13,889
MAPLIGHT THERAPEUTICS INC(MPLT)0611,447+611,447010,7434.15%+10,743
IMMUNOME INC(IMNM)502,512732,512+230,0005,88415,7346.08%+9,850
OCULIS HOLDING AG2,300,7742,288,658-12,11640,44845,70517.67%+5,257
BIOAGE LABS INC(BIOA)653,374653,37403,8428,6443.34%+4,802
TREVI THERAPEUTICS INC(TRVI)1,256,7821,256,782011,50015,7356.08%+4,235
ZENAS BIOPHARMA INC(ZBIO)779,045591,991-187,05417,29521,4958.31%+4,200
RALLYBIO CORP2,404,6442,404,64401,2001,6500.64%+450
BOLT BIOTHERAPEUTICS INC94,57394,57305035170.20%+14
ARCUTIS BIOTHERAPEUTICS INC(ARQT)2,120,5081,366,624-753,88439,97239,68715.34%-285
RECURSION PHARMACEUTICALS IN(RXRX)595,518595,51802,9062,4360.94%-470
Page 1 of 1